Lupin is aiming to launch its first biosimilar product and commercialize its first inhalation product in the US in the current fiscal. The new launches across the globe would help it achieve sustainable growth.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.